Researchers in Infection Biology are working to combat the global health emergencies of today and the future.
Fueled by an increasingly interconnected world, population growth and climate change, infectious diseases are a growing threat to public health. Outbreaks can spread rapidly and are responsible for 15 million deaths each year. Now more than ever, effective responses to emerging global health emergencies will require research and optimized infrastructure to support discoveries.More About Us
The Christine O'Connor lab researches cytomegalovirus infection, pathogenesis and disease.Learn More
The Foo lab researches viral infections during pregnancy, specifically viral pathogensis and maternal-fetal immunology, in emerging pathogens including Zika virus and high-risk SARS-CoV-2.Learn More
The Xianfang Wu lab studies stem cell resistance to viral infections and develops liver and infectious disease models.Learn More
Dr. Jae Jung will study the natural course of infection and viral reassortment of the emerging pathogen, Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV).
In this newly created role, he will lead the development of novel vaccine platforms for a variety of infectious diseases, including influenza, HIV and COVID-19.
Dr. Jung and his team of researchers published the novel COVID-19 study, which details the critical role viral gene ORF8 plays in infection and outcomes rates, using samples from Cleveland Clinic’s BioRepository.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Infection Biology Program.View Careers